LONDON (Reuters) – European shares rose to a record high on Thursday, lifted by a rally in global stocks that also saw Japan’s blue-chip Nikkei index hit an all-time high. Europe’s broad STOXX 600 index rose to 495.81 points, surpassing the 495.46 reached in Jan. 2022, as unexpectedly strong revenue forecasts from U.S. chip giant …
Instant view: Europe’s stock market rallies to record high Read More »
By Carolyn Cohn and Miranda Murray LONDON (Reuters) -Zurich Insurance posted a better than expected annual operating profit on Thursday and announced a share buyback of up to 1.1 billion Swiss francs ($1.25 billion), as insurers ride out the impact of a global pandemic, wars and climate disasters. Operating profit at Europe’s fifth-largest insurer rose …
Zurich Insurance announces $1.25 billion buyback after record profit Read More »
LONDON (Reuters) – The downturn in euro zone business activity eased in February as the dominant services sector broke a six-month streak of contraction, offsetting a deterioration in manufacturing, a survey showed. HCOB’s preliminary composite PMI, compiled by S&P Global, rose to 48.9 this month from January’s 47.9, ahead of expectations in a Reuters poll …
Downturn in euro zone business activity eases in Feb -PMI Read More »
By Richa Naidu and Dominique Vidalon LONDON/PARIS (Reuters) – Two of the world’s top consumer goods companies, Danone and Nestle, said on Thursday they will slow price increases in 2024 after two years of hikes that have prompted shoppers to seek cheaper alternatives for basic goods like yoghurt and coffee. But Danone, which owns brands …
Nestle, Danone see price hikes slowing after years of sharp increases Read More »
BERLIN (Reuters) – Germany’s economic downturn deepened in February as a slight improvement in services activity was unable to compensate for a surprisingly sharp deterioration in manufacturing, a preliminary survey showed on Thursday. The HCOB German Flash Composite Purchasing Managers’ Index (PMI), compiled by S&P Global, fell to 46.1 in February from 47.0 the month …
German economic downturn deepens unexpectedly in February -PMI Read More »
By Clara Denina and Felix Njini LONDON (Reuters) -Anglo American said on Thursday it will review its assets after posting a 94% plunge in its annual profit and taking writedowns at its diamonds and nickel units. The miner announced a $1.6 billion impairment charge on its De Beers diamond business owing to faltering demand, and …
Anglo American launches asset review after writedowns, profit plunge Read More »
By Arsheeya Bajwa and Max A. Cherney (Reuters) -Nvidia on Wednesday forecast a roughly threefold surge in quarterly revenue that handily beat estimates as the company banked on towering demand for its industry-leading artificial-intelligence chips, sending its shares up 10% after-hours. The already-hefty demand for the company’s data center chips and graphics processing units (GPUs) …
Nvidia stock surges as revenue forecast tops estimates, AI demand continues Read More »
(Reuters) -Australian building materials firm CSR Ltd has backed an A$4.30 billion ($2.81 billion) non-binding takeover proposal from French construction materials group Saint-Gobain <SGOB.PA>, granting it access to its books to make a final offer. The offer price of A$9.0 per share is at a premium of 13.2% to CSR’s last close. On Wednesday, CSR …
Australia’s CSR backs $2.8 billion takeover offer from Saint-Gobain Read More »
(Reuters) – Live-video shopping app NTWRK said on Wednesday it would buy publisher Complex, in a bid to leverage the popularity of the publication to reach younger audience. The new company will be led by Aaron Levant, who co-founded NTWRK in 2018 and has served as its CEO since its inception. “We will create the …
Live-video shopping app NTWRK to buy publisher Complex Read More »
(Reuters) – Britain’s health regulator said on Wednesday it had revoked a conditional marketing authorisation for Novartis’ sickle cell disease drug, Adakveo. The decision follows the Swiss drugmaker’s move to recall a batch of the drug after the Medicines and Healthcare products Regulatory Agency (MHRA) said it no longer considered the treatment’s benefits-to-risk balance favourable. …
UK’s MHRA revokes authorisation for Novartis’ sickle cell drug Read More »
